FORM SC 13G

Company

Celldex Therapeutics, Inc.

Filed

September 1, 1998

Accession Number

0000950116-98-001817

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →